Diagnosis and Management of Multiple Sclerosis
Diagnosis and Management of Multiple Sclerosis
Diagnosis and Management of Multiple Sclerosis
Findings on Examination
:focus on long white matter tracts:
Eye:Optic neuritis
- funduscopy results are usually normal: UNLESS your pt is a chronic sufferer,
in which case expect OPTIC NERVE ATROPHY: a pale and useless-looking optic disk
"The patient sees nothing and the doctor sees nothing."
-Light Reaction: afferent pupillary defect (i.e cant see thus cant react)
may be seen in the affected eye.
- Visual acuity usually is impaired (ie, subtle to total blindness).
- internuclear ophthalmoplegia (INO) = classic finding; a lesion in the median longitudinal
fasciculus (MLF) resulting in
- a weakness in adduction of the ipsilateral eye
- nystagmus on abduction of the contralateral eye,
- an incomplete or slow abduction of the ipsilateral eye upon lateral gaze,
- complete preservation of convergence.
- abnormal pupillary responses,
- acquired pendular nystagmus : rapid, small amplitude pendular oscillations of the eyes in the
primary position resembling quivering jelly. Patients frequently complain of oscillopsia
(subjective jumping/jerking of objects in the field of vision), which impairs visual performance
- loss of smooth eye pursuit.
YOU HAVE TO FIND ONE OF THESE SIGNS TO EVEN CONSIDER A DIAGNOSIS OF MS
Spinal Cord Symptoms
= indicative of upper motor neuron dysfunction, as long white matter highways is what the SC is all about
- Sphincter paralysis = bladder, bowel, and sexual dysautonomias.
- Paralysis
- Spasticity
- hyperreflexia
- Decreased joint position and vibration sense
- Decreased pain and temperature (less common)
Cerebellar symptoms:
- Disequilibrium,
- truncal or limb ataxia,
- scanning (ie, monotonous) speech,
- intention tremor,
- saccadic dysmetria
Lhermitte sign: Neck flexion results in an electric shocklike feeling in the torso or extremities
Tests and Investigations
Visually Evoked Potentials
The individual visual evoked potentials
with the major scotoma superimposed
(grey-shaded area).
Disease Definition
Multiple sclerosis (MS) is an idiopathic inflammatory demyelinating disease of the CNS.
MS is characterized by
(1) a relapsing-remitting or progressive course and
(2) a pathologic triad of CNS inflammation, demyelination, and gliosis (scarring).
Lesions of MS are classically said to be disseminated in time and space.
Management
ACUTE:
Hit them with steroids right away if you suspect an acute lesion in progress:
DRUG ‘O’ CHOICE: IV infusion Methylprednisolone 3-5days
Mechanisms of action same as for Cortisol (but more potent (5x anti-inflammatory)
and does not stimulate Na retention. Decreases inflammation by suppressing
migration of polymorphonuclear leukocytes and reversing increased capillary
permeability.
NO LONG TERM BENEFIT but duration of attack is reduced
LONG TERM:
Aim is to slow progression and delay onset of SUSTAINED PROGRESSION
DRUGS which do this include:
- INTERFERON BETA 1a
- INTERVERON BETA 1b
IFNs have nasty side effects such as
- Injection site reactions;
- Flu-like symptoms;
- CNS disturbances incl. depression and suicidal ideation;
- Leucopenia;
- Menstrual disturbances
- Elevated hepatic enzymes;
- Hypersensitivity reactions;
- COPAXONE (glatiramer acetate)
is practically the same except side-effects are nicer,
eg. no menstrual disorders or depression.
The mechanism is unknown, but it seems to decrease the frequency of relapses
- MARIJUANA : although anecdotally patients report improvements in ataxia and spasticity,
this management option is not supported by world literature and thus cannot be recommended
with a straight face.